Dr. Wood is a Board-Certified Adult Psychiatrist who is focused on treating mood disorders and depression. His area of professional focus has been treatment-resistant psychiatric illnesses, the interplay of medical and psychiatric disorders, interventional psychiatry, as well as an interest in the reemergence of psychedelic-assisted therapy modalities in the treatment of psychiatric disorders like treatment-resistant depression and PTSD.
He has been fascinated with biology, the human body, and medicine since high school. He expanded that interest to organic chemistry and neuroscience in college as well as to broader philosophical questions around the nature and subjectivity of conscious experience. In medical school, he had the opportunity to work in an outpatient clinic with his own supervised patient panel, was exposed to mindfulness-based practices, and learned of the effectiveness of utilizing integrated modalities to alleviate the common yet inherently difficult experiences of stress, anxiety, and depression. Over the course of residency training, he witnessed first-hand how his patients were able to improve their quality of life when given an attentive presence, utilizing psychotherapeutic principles, as well as a thoughtful consideration of the use of psychotropic medication. For him, psychiatry encompasses many of the interests he has been cultivating over the years and he is excited about the many innovative treatments on the horizon.
When working with patients, Dr. Wood provides a compassionate and collaborative approach that utilizes up-to-date knowledge of psychotherapeutic, psychopharmacologic, and somatic treatment modalities to help his patients achieve their specific treatment goals. He takes a holistic view of the person and the circumstances that have brought them to seek professional assistance. He believes that the cultivation of a balanced sense of well-being is an achievable goal.
Dr. Wood finds that both TMS and esketamine can be effective in patients with depression for whom traditional medication management and psychotherapeutic approaches have been only partially effective or altogether ineffective. Having safe and effective treatments like TMS or esketamine available in the office setting provides more latitude to help patients, particularly those who haven’t been able to achieve remission with medications and talk therapy.
He joins TMS Health Solutions in the Summer of 2021.
Dr. Wood enjoys the diversity of culture and experience that thrives in the Bay Area. He finds it amazing that in a single day, one could hike amongst the Redwoods in Marin or Oakland, view mind-blowing art at the SF MoMA, enjoy world-class food in any of the culturally diverse neighborhoods, and then watch the sunset at Ocean Beach. Outside of work, he likes to play music, card and video games, hike (preferably amongst Redwoods), and explore the natural beauty of the West Coast.
Dr. Wood received his Bachelor of Science in Biology, Summa Cum Laude, from the University of Kentucky, Lexington, Kentucky.
He received his medical degree from the University of Louisville School of Medicine, where he first developed his interest in the interaction between the mind and body.
Upon completion of medical school, he entered residency training in psychiatry at Washington University in St. Louis. While at Washington University he became actively involved in medical student education, conducted research examining the relationship between personality characteristics and subjective well-being in patients with severe mental illness, and developed an interest in methods of mental healthcare delivery in the outpatient setting. During his time in Residency, he received a first-place clinical research award at the Washington University Department of Psychiatry’s Fourth Annual Post- and Pre-doctoral Fellows Symposium & Networking Event.
Following residency, Dr. Wood completed a master’s program in Population Health Sciences at the Washington University School of Medicine to further his knowledge of public health and statistical methods in medicine.
He completed a Clinical Fellowship at the University of California, San Francisco (UCSF) Medical School. During this time, he conducted research addressing the needs of underserved and LGBTQ-identifying populations undergoing substance use disorder treatment as part of a collaborative research project.
He was Senior Physician Specialist at the San Francisco Dept. of Public Health, Central City Older Adults.
He served as an Assistant Clinical Professor in the Department of Psychiatry at UCSF and worked as an attending physician at San Francisco General Hospital providing patient, teaching trainees, and contributing to departmental improvements. During this time, he received an award for Excellence in Clinical Teaching from the residents.
Utilizing measures of client motivation and PTSD symptoms as indicators of completion in residential substance use disorder treatment in the public mental health system. Keith Wood, MD, MPHS; Melanie Thomas, MD, MS; James Dilley, MD; Scott Collier, MSW, Ph.D.; Joshua Parmenter, BA; Martha Shumway, Ph.D.; Christina Mangurian, MD, MAS. (Presented at the American Psychiatric Association Annual Meeting Poster Session, May 2016)
Cannabinoid Hyperemesis Syndrome Masquerading as a Psychotic Disorder. M. Earth Hassasri, MD; Keith Wood, MD. (Presented at the APA Institute on Psychiatric Services Meeting Poster Session, October 2019)